KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) EBITDA: 2013-2025

Historic EBITDA for CareDx (CDNA) over the last 12 years, with Sep 2025 value amounting to -$246,000.

  • CareDx's EBITDA rose 98.21% to -$246,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $59.6 million, marking a year-over-year increase of 135.87%. This contributed to the annual value of $40.8 million for FY2024, which is 120.05% up from last year.
  • According to the latest figures from Q3 2025, CareDx's EBITDA is -$246,000, which was up 97.79% from -$11.1 million recorded in Q2 2025.
  • CareDx's 5-year EBITDA high stood at $84.4 million for Q4 2024, and its period low was -$122.6 million during Q4 2023.
  • Moreover, its 3-year median value for EBITDA was -$13.7 million (2024), whereas its average is -$17.0 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 2,120.63% in 2022, then soared by 168.81% in 2024.
  • CareDx's EBITDA (Quarterly) stood at -$15.4 million in 2021, then declined by 24.16% to -$19.1 million in 2022, then crashed by 541.38% to -$122.6 million in 2023, then soared by 168.81% to $84.4 million in 2024, then spiked by 98.21% to -$246,000 in 2025.
  • Its EBITDA was -$246,000 in Q3 2025, compared to -$11.1 million in Q2 2025 and -$13.4 million in Q1 2025.